NOWDiagnostics Raises $22.5M in Series B Funding for OTC and POC Tests Expansion
NOWDiagnostics Raises $22.5M in Series B Funding
NOWDiagnostics raises $22.5M in Series B Funding
NOWDiagnostics (Linkedin), a leader in over-the-counter and point-of-care diagnostic tests, recently secured $22.5M in Series B funding. Their innovative solutions cater to healthcare providers, clinics, and consumers, offering accurate and convenient diagnostic testing options.
Funding Amount: $22.5 million
Industry: Medical Equipment Manufacturing
Employee Count: 11-50
CEO: Robert Weigle (CEO Linkedin)
What NOWDiagnostics needs to buy: Manufacturing partners, research and development collaborations, and marketing and distribution partnerships are ideal for NOWDiagnostics. These companies can support NOWDiagnostics in scaling production, expanding their test pipeline, and reaching a wider customer base in the at-home and point-of-care diagnostic testing market.